Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2010-04-12 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLENEUVE-LES-MAGUELONE (34750), Herault
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE MAZERAND : revenue, balance sheet and financial ratios
PHARMACIE MAZERAND is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLENEUVE-LES-MAGUELONE (34750),
this company of category PME
shows in 2024 a net income positive of 271 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE MAZERAND (SIREN 521709188)
Indicator
2024
2023
2022
2021
2020
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
271 359 €
375 274 €
565 879 €
242 411 €
216 121 €
215 027 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE MAZERAND generates positive net income of 271 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 215 k€ -> 271 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
271 359 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 16%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
15.725%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.815%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2020
2021
2022
2023
2024
Debt ratio
88.133
61.222
42.141
25.756
24.584
15.725
Financial autonomy
41.454
51.225
57.432
63.656
65.612
68.815
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
15.722024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent
In 2024, the debt ratio of PHARMACIE MAZERAND (15.72) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
68.81%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good
In 2024, the financial autonomy of PHARMACIE MAZERAND (68.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 114.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
114.133
Liquidity indicators evolution PHARMACIE MAZERAND
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2020
2021
2022
2023
2024
Liquidity ratio
96.894
138.114
119.177
153.511
153.074
114.133
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
114.132024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch-6 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE MAZERAND (114.13) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE MAZERAND in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE MAZERAND is estimated at
3 788 372 €
(range 2 638 162€ - 5 667 621€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2638k€3788k€5667k€
3 788 372 €Range: 2 638 162€ - 5 667 621€
NAF 5 année 2024
Valuation method used
Net Income Multiple
271 359 €
×
14.0x
=3 788 372 €
Range: 2 638 163€ - 5 667 622€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE MAZERAND with other companies in the same sector:
Frequently asked questions about PHARMACIE MAZERAND
What is the revenue of PHARMACIE MAZERAND ?
The revenue of PHARMACIE MAZERAND is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE MAZERAND profitable?
Yes, PHARMACIE MAZERAND generated a net profit of 271 k€ in 2024.
Where is the headquarters of PHARMACIE MAZERAND ?
The headquarters of PHARMACIE MAZERAND is located in VILLENEUVE-LES-MAGUELONE (34750), in the department Herault.
Where to find the tax return of PHARMACIE MAZERAND ?
The tax return of PHARMACIE MAZERAND is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE MAZERAND operate?
PHARMACIE MAZERAND operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart